Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2002;8(5):392–399. doi: 10.1080/13550280260422695

Differential induction of apoptosis in demyelinating and nondemyelinating infection by mouse hepatitis virus

Talya Schwartz 1, Li Fu 1, Ehud Lavi 1,
PMCID: PMC7094974  PMID: 12402165

Abstract

The role of apoptosis in mouse hepatitis virus (MHV) infection is still controversial. To better assess the role of apoptosis in MHV infection, we used three different biologic phenotypes of MHV to examine their differential effect on the induction of apoptosis. MHV-A59 produces acute hepatitis, meningoencephalitis, and chronic demyelination. MHV-2 causes only acute hepatitis and meningitis, whereas Penn98-1 produces acute hepatitis and meningoencephalitis without demyelination. We detected TdT-mediated dUTP nick-end labeling (TUNEL) staining in the livers and meninges of MHV-A59-, MHV-2-, and Penn98-1-infected mice. TUNEL staining in brain parenchyma was only detected in MHV-A59- and Penn98-1-infected mice. We detected apoptosis by electron-microscopy in olfactory neurons during acute infection with MHV-A59. The kinetics and distribution of TUNEL staining correlated with the pathologic damage and colocalized with viral antigen in some cells. At 1 month, TUNEL staining was found exclusively in areas of demyelination in the spinal cord of MHV-A59-infected mice; however, it was not found in nondemyelinated mice infected with MHV-2 or Penn98-1, or in mock-infected mice. TUNEL-positive cells were identified as macrophage/microglial cells, some astrocytes, and some oligodendrocytes, by colabeling with cell-specific markers. The presence of TUNEL staining in oligodendrocytes suggests that apoptosis may play an important role in MHV-induced demyelination.

Keywords: apoptosis, coronaviruses, demyelination, mouse hepatitis virus, multiple sclerosis, Nidovirales

Footnotes

This work was supported in part by a grant from the National Multiple Sclerosis Society (RG 2615) and a PHS grant NS30606.

References

  1. An S, Chen CJ, Yu X, Leibowitz JL, Makino S. Induction of apoptosis in murine coronavirus-infected cultured cells and demonstration of E protein as an apoptosis inducer. J Virol. 1999;73:7853–7859. doi: 10.1128/jvi.73.9.7853-7859.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bansil S, Holtz CR, Cook SD, Rohowsky-Kochan C. Serum sAPO-1/Fas levels in multiple sclerosis. Acta Neurol Scand. 1997;95:208–210. doi: 10.1111/j.1600-0404.1997.tb00100.x. [DOI] [PubMed] [Google Scholar]
  3. Barac-Latas V, Suchanek G, Breitschopf H, Stuehler A, Wege H, Lassmann H. Patterns of oligodendrocyte pathology in coronavirus-induced subacute demyelinating encephalomyelitis in the Lewis rat. Glia. 1997;19:1–12. doi: 10.1002/(SICI)1098-1136(199701)19:1<1::AID-GLIA1>3.0.CO;2-5. [DOI] [PubMed] [Google Scholar]
  4. Bonetti B, Pohl J, Gao YL, Raine CS. Cell death during autoimmune demyelination: Effector but not target cells are eliminated by apoptosis. J Immunol. 1997;159:5733–5741. [PubMed] [Google Scholar]
  5. Bonetti B, Raine CS. Multiple sclerosis: Oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann Neurol. 1997;42:74–84. doi: 10.1002/ana.410420113. [DOI] [PubMed] [Google Scholar]
  6. Budzilowicz CJ, Wilczynski SP, Weiss SR. Three intergenic regions of mouse hepatitis virus strain A59 genome RNA contain a common nucleotide sequence that is homologous to the 3′ end of the viral mRNA leader sequence. J Virol. 1985;53:834–840. doi: 10.1128/jvi.53.3.834-840.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cammer W, Sacchi R, Sapirstein V. Immunocytochemical localization of carbonic anhydrase in the spinal cords of normal and mutant (shiverer) adult mice with comparisons among fixation methods. J Histochem Cytochem. 1985;33:45–54. doi: 10.1177/33.1.3917467. [DOI] [PubMed] [Google Scholar]
  8. Ciusani E, Frigerio S, Gelati M, Corsini E, Dufour A, Nespolo A, La Mantia L, Milanese C, Massa G, Salmaggi A. Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol. 1998;82:5–12. doi: 10.1016/S0165-5728(97)00177-X. [DOI] [PubMed] [Google Scholar]
  9. Clem RJ, Fechheimer M, Miller LK. Prevention of apoptosis by a baculovirus gene during infection of insect cells. Science. 1991;254:1388–1390. doi: 10.1126/science.1962198. [DOI] [PubMed] [Google Scholar]
  10. Das Sarma J, Fu L, Hingley ST, Lai MM, Lavi E. Sequence analysis of the S gene of recombinant MHV-2/A59 coronaviruses reveals three candidate mutations associated with demyelination and hepatitis. J NeuroVirol. 2001;7:432–436. doi: 10.1080/135502801753170282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Das Sarma J, Fu L, Hingley ST, Lavi E. Mouse hepatitis virus type-2 infection in mice: An experimental model system of acute meningitis and hepatitis. Exp Mol Pathol. 2001;71:1–12. doi: 10.1006/exmp.2001.2378. [DOI] [PubMed] [Google Scholar]
  12. Das Sarma J, Fu L, Tsai JC, Weiss SR, Lavi E. Demyelination determinants map to the spike glycoprotein gene of coronavirus mouse hepatitis virus. J Virol. 2000;74:9206–9213. doi: 10.1128/JVI.74.19.9206-9213.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dowling P, Husar W, Menonna J, Donnenfeld H, Cook S, Sidhu M. Cell death and birth in multiple sclerosis brain. J Neurol Sci. 1997;149:1–11. doi: 10.1016/S0022-510X(97)05213-1. [DOI] [PubMed] [Google Scholar]
  14. D’Souza SD, Bonetti B, Balasingam V, Cashman NR, Barker PA, Troutt AB, Raine CS, Antel JP. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med. 1996;184:2361–2370. doi: 10.1084/jem.184.6.2361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fishman PS, Gass JS, Swoveland PT, Lavi E, Highkin MK, Weiss SR. Infection of the basal ganglia by a murine coronavirus. Science. 1985;229:877–879. doi: 10.1126/science.2992088. [DOI] [PubMed] [Google Scholar]
  16. Furlan R, Martino G, Galbiati F, Poliani PL, Smiroldo S, Bergami A, Desina G, Comi G, Flavell R, Su MS, Adorini L. Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. J Immunol. 1999;163:2403–2409. [PubMed] [Google Scholar]
  17. Griffin DE, Levine B, Tyor WR, Tucker PC, Hardwick JM. Age-dependent susceptibility to fatal encephalitis: Alphavirus infection of neurons. Arch Virol Suppl. 1994;9:31–39. doi: 10.1007/978-3-7091-9326-6_4. [DOI] [PubMed] [Google Scholar]
  18. Griffin DE, Levine B, Ubol S, Hardwick JM. The effects of alphavirus infection on neurons. Ann Neurol. 1994;35:S23–S27. doi: 10.1002/ana.410350709. [DOI] [PubMed] [Google Scholar]
  19. Keck JG, Soe LH, Makino S, Stohlman SA, Lai MMC. RNA recombination of murine coronavirus: Recombination between fusion-positive mouse hepatitis virus A59 and fusion-negative mouse hepatitis virus 2. J Virol. 1988;62:1989–1998. doi: 10.1128/jvi.62.6.1989-1998.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lai MMC, Cavanagh D. The molecular biology of coronaviruses. Adv Virus Res. 1997;48:1–100. doi: 10.1016/S0065-3527(08)60286-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lavi E, Fishman SP, Highkin MK, Weiss SR. Limbic encephalitis following inhalation of murine coronavirus MHV-A59. Lab Invest. 1988;58:31–36. [PubMed] [Google Scholar]
  22. Lavi E, Gilden DH, Highkin MK, Weiss SR. Persistence of MHV-A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization. J Virol. 1984;51:563–566. doi: 10.1128/jvi.51.2.563-566.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lavi E, Gilden DH, Highkin MK, Weiss SR. The organ tropism of mouse hepatitis virus A59 is dependent on dose and route of inoculation. Lab Anim Sci. 1986;36:130–135. [PubMed] [Google Scholar]
  24. Lavi E, Gilden DH, Wroblewska Z, Rorke LB, Weiss SR. Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology. 1984;34:597–603. doi: 10.1212/wnl.34.5.597. [DOI] [PubMed] [Google Scholar]
  25. Lavi E, Schwartz T, Jin YP, Fu L. Nidovirus infections: Experimental model systems of human neurologic diseases. J Neuropathol Exp Neurol. 1999;58:1197–1206. doi: 10.1097/00005072-199912000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lavi E, Wang Q, Stieber A, Gonatas NK. Polarity of processes with Golgi apparatus in a subpopulation of type I astrocytes. Brain Res. 1994;647:273–285. doi: 10.1016/0006-8993(94)91327-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lavi E, Weiss SR. Coronaviruses. In: Gilden DH, Lipton HL, editors. Clinical and molecular aspects of neurotropic viral infections. Boston, MA: Kluwer Academic Publishers; 1989. pp. 101–139. [Google Scholar]
  28. Lee VM-Y, Page CD, Wu HL, Schlaepfer WW. Monoclonal antibodies to gel excised glial filament protein and their reactivities with other intermediate filament proteins. J Neurochem. 1984;42:25–25. doi: 10.1111/j.1471-4159.1984.tb09692.x. [DOI] [PubMed] [Google Scholar]
  29. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol. 1995;146:3–15. [PMC free article] [PubMed] [Google Scholar]
  30. Navas S, Seo S, Chua MM, Das Sarma J, Lavi E, Hingley ST, Weiss SR. The spike protein of murine coronavirus determines the ability of the virus to replicate in the liver and cause hepatitis. J Virol. 2001;75:2452–2457. doi: 10.1128/JVI.75.5.2452-2457.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Okuda Y, Bernard CC, Fujimura H, Yanagihara T, Sakoda S. Fas has a crucial role in the progression of experimental autoimmune encephalomyelitis. Mol Immunol. 1998;35:317–326. doi: 10.1016/S0161-5890(98)00049-2. [DOI] [PubMed] [Google Scholar]
  32. Osborne BA. Apoptosis and the maintenance of homoeostasis in the immune system. Curr Opin Immunol. 1996;8:245–254. doi: 10.1016/S0952-7915(96)80063-X. [DOI] [PubMed] [Google Scholar]
  33. Palma JP, Yauch RL, Lang S, Kim BS. Potential role of CD4+ T cell-mediated apoptosis of activated astrocytes in Theiler’s virus-induced demyelination. J Immunol. 1999;162:6543–6551. [PubMed] [Google Scholar]
  34. Parra B, Lin MT, Stohlman SA, Bergmann CC, Atkinson R, Hinton DR. Contributions of fas-Fas ligand interactions to the pathogenesis of mouse hepatitis virus in the central nervous system. J Virol. 2000;74:2447–2450. doi: 10.1128/JVI.74.5.2447-2450.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Razvi ES, Welsh RM. Apoptosis in viral infections. Adv Virus Res. 1995;45:1–60. doi: 10.1016/S0065-3527(08)60057-3. [DOI] [PubMed] [Google Scholar]
  36. Sabelko KA, Kelly KA, Nahm MH, Cross AH, Russell JH. Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. J Immunol. 1997;159:3096–3099. [PubMed] [Google Scholar]
  37. Shibata S, Kyuwa S, Lee SK, Toyoda Y, Goto N. Apoptosis induced in mouse hepatitis virus-infected cells by a virus-specific CD8+ cytotoxic T-lymphocyte clone. J Virol. 1994;68:7540–7545. doi: 10.1128/jvi.68.11.7540-7545.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Tsunoda I, Fujinami RS. Two models for multiple sclerosis: Experimental allergic encephalomyelitis and Theiler’s murine encephalomyelitis virus. J Neuropathol Exp Neurol. 1996;55:673–686. doi: 10.1097/00005072-199606000-00001. [DOI] [PubMed] [Google Scholar]
  39. Tsunoda I, Kurtz CI, Fujinami RS. Apoptosis in acute and chronic central nervous system disease induced by Theiler’s murine encephalomyelitis virus. Virology. 1997;228:388–393. doi: 10.1006/viro.1996.8382. [DOI] [PubMed] [Google Scholar]
  40. Waldner H, Sobel RA, Howard E, Kuchroo VK. Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J Immunol. 1997;159:3100–3103. [PubMed] [Google Scholar]
  41. Wu GF, Perlman S. Macrophage infiltration, but not apoptosis, is correlated with immune-mediated demyelination following murine infection with a neurotropic coronavirus. J Virol. 1999;73:8771–8780. doi: 10.1128/jvi.73.10.8771-8780.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Zipp F, Weller M, Calabresi PA, Frank JA, Bash CN, Dichgans J, McFarland HF, Martin R. Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis. Ann Neurol. 1998;43:116–120. doi: 10.1002/ana.410430120. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurovirology are provided here courtesy of Nature Publishing Group

RESOURCES